Merck enters the lab-grown meat space by investing in MosaMeat

October 02, 2018 | Case Study

M Ventures, the corporate venture capital arm of pharmaceutical giant Merck, co-led the Series A funding round of Dutch startup MosaMeat, which develops cultured meat from bovine cells. Interestingly, this is Merck's first investment in companies developing lab-grown meat. After making this initial investment, Merck has announced its accelerator program and sustained interest to support more startups in this space. It has identified cultured meat as an "Innovation Field" in which the company sees potential for new business.

About Lux Research

Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.

Already a Lux Client?

Sign In

Interested in Learning More?

Contact us to learn the benefits of becoming a Lux member.

Or call us now

For North America (Boston Headquarters)
+1 (617) 502-5300

For EMEA (Amsterdam)
+31 20 280 7900

For APAC (Singapore)
+65 6592-6978